These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3533682)
41. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856 [TBL] [Abstract][Full Text] [Related]
42. Sexual dimorphism of hyperglycemia and glucose tolerance in Wistar fatty rats. Kava RA; West DB; Lukasik VA; Greenwood MR Diabetes; 1989 Feb; 38(2):159-63. PubMed ID: 2644138 [TBL] [Abstract][Full Text] [Related]
43. Dynamics of pancreatic insulin release in young Zucker rats: a heterozygote effect. Blonz ER; Stern JS; Curry DL Am J Physiol; 1985 Feb; 248(2 Pt 1):E188-93. PubMed ID: 3881986 [TBL] [Abstract][Full Text] [Related]
44. Chronic insulin infusion induces reversible glucose intolerance in lean rats yet ameliorates glucose intolerance in obese rats. Hamza SM; Sung MM; Gao F; Soltys CM; Smith NP; MacDonald PE; Light PE; Dyck JR Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):313-322. PubMed ID: 27871838 [TBL] [Abstract][Full Text] [Related]
45. Acute intravenous corticotropin-releasing factor administration: effects on insulin secretion in lean and genetically obese fa/fa rats. Rohner-Jeanrenaud F; Jeanrenaud B Endocrinology; 1992 Apr; 130(4):1903-8. PubMed ID: 1312430 [TBL] [Abstract][Full Text] [Related]
46. Local cerebral glucose utilization in brains of lean and genetically obese (fa/fa) rats. Doyle P; Rohner-Jeanrenaud F; Jeanrenaud B Am J Physiol; 1993 Jan; 264(1 Pt 1):E29-36. PubMed ID: 8430785 [TBL] [Abstract][Full Text] [Related]
47. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Meneilly GS; Elliott T Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911 [TBL] [Abstract][Full Text] [Related]
49. Modulation by glucose of insulin secretion and glucose phosphorylating activity in cultured pancreatic islets from obese (fa/fa) Zucker rats. Chan CB; Lowe JM; Debertin WJ Int J Obes Relat Metab Disord; 1996 Feb; 20(2):175-84. PubMed ID: 8646255 [TBL] [Abstract][Full Text] [Related]
50. Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance. Henriksen EJ; Jacob S; Fogt DL; Dietze GJ Am J Physiol; 1998 Jul; 275(1):R40-5. PubMed ID: 9688958 [TBL] [Abstract][Full Text] [Related]
51. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171 [TBL] [Abstract][Full Text] [Related]
52. Circadian changes in serum and liver metabolites and liver lipogenic enzymes in ad libitum- and meal-fed, lean and obese Zucker rats. Lanza-Jacoby S; Stevenson NR; Kaplan ML J Nutr; 1986 Sep; 116(9):1798-809. PubMed ID: 3761034 [TBL] [Abstract][Full Text] [Related]
53. Influence of phytostanol phosphoryl ascorbate (FM-VP4) on insulin resistance, hyperglycemia, plasma lipid levels, and gastrointestinal absorption of exogenous cholesterol in Zucker (fa/fa) fatty and lean rats. Wasan KM; Zamfir C; Pritchard PH; Pederson RA J Pharm Sci; 2003 Feb; 92(2):281-8. PubMed ID: 12532378 [TBL] [Abstract][Full Text] [Related]
54. Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. Basu A; Alzaid A; Dinneen S; Caumo A; Cobelli C; Rizza RA J Clin Invest; 1996 May; 97(10):2351-61. PubMed ID: 8636416 [TBL] [Abstract][Full Text] [Related]
55. Hyperinsulinemia of preobese and obese fa/fa rats is partly vagus nerve mediated. Rohner-Jeanrenaud F; Hochstrasser AC; Jeanrenaud B Am J Physiol; 1983 Apr; 244(4):E317-22. PubMed ID: 6340520 [TBL] [Abstract][Full Text] [Related]
56. Identification of a major defect in insulin-resistant tissues of genetically obese (fa/fa) rats. Impaired protein kinase C. van de Werve G; Zaninetti D; Lang U; Vallotton MB; Jeanrenaud B Diabetes; 1987 Mar; 36(3):310-4. PubMed ID: 3803738 [TBL] [Abstract][Full Text] [Related]
57. Thiazolidinediones influence plasma steroids of male obese Zucker rats. Fürnsinn C; Nowotny P; Brunmair B; Gras F; Roden M; Waldhäusl W; Vierhapper H Endocrinology; 2002 Jan; 143(1):327. PubMed ID: 11751625 [TBL] [Abstract][Full Text] [Related]
58. Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine. Pénicaud L; Hitier Y; Ferré P; Girard J Biochem J; 1989 Sep; 262(3):881-5. PubMed ID: 2686622 [TBL] [Abstract][Full Text] [Related]
59. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. Cefalu WT; Wang ZQ; Zhang XH; Baldor LC; Russell JC J Nutr; 2002 Jun; 132(6):1107-14. PubMed ID: 12042418 [TBL] [Abstract][Full Text] [Related]